Analysis of the Application of Antiviral Drugs for Hepatitis B in a Hospital from 2010 to 2014
10.6039/j.issn.1001-0408.2016.05.08
- VernacularTitle:某院2010-2014年抗乙肝病毒药物使用分析
- Author:
Jiangli WENG
;
Weiguo ZHAO
;
Guoqin LAO
- Publication Type:Journal Article
- Keywords:
Antiviral drugs for hepatitis B viral;
Nucleoside(acid)analogues;
Interferons;
Analysis of drug use
- From:
China Pharmacy
2016;27(5):601-603
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To provide reference for rational use of antiviral drugs for hepatitis B viral (HBV) in the clinic. METHODS:The application of antiviral drugs for HBV in a hospital during 2010-2014 was analyzed statistically in respects of con-sumption sum,DDDs,serial number ratio(B/A),etc. RESULTS:Total consumption sum of antiviral drugs for HBV in a hospital increased from 5 698 200 yuan to 20 115 600 yuan during 2010-2014,and annual average rate of growth (AARG) of entecavir 76.37%. The consumption sum of ordinary interferon decreased year by year,with AARG of -20.30%. Besides DDDs of ordinary interferon declined year by year,DDDs of all antiviral drugs for HBV showed a trend of increased year by year,among which the increase of entecavir was the most obvious,being 1 366.30%from 2010 to 2014. The B/A value of lamivudine,telbivudine and or-dinary interferon were equal to or close to 1 for consecutive 5 years,and the number of patients was well synchronized with con-sumption sum. CONCLUSIONS:Nucleoside (acid) analogues has become an important method of HBV antiviral treatment,and the drugs should be selected reasonably according to the specific condition of patients in clinical treatment,in order to improve the safety,effectiveness and economy of treatment.
